Showing results (191-200 of 232) with videos related to

Sort By:
Pageof 24
American Heart Journal|December 13, 2006
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trialHarvey D White, Neal S Kleiman, Kenneth W Mahaffey, et al.
American Heart Journal|March 20, 2012
A multifaceted intervention to narrow the evidence-based gap in the treatment of acute coronary syndromes: rationale and design of the Brazilian Intervention to Increase Evidence Usage in Acute Coronary Syndromes (BRIDGE-ACS) cluster-randomized trialOtávio Berwanger, Hélio P Guimarães, Ligia N Laranjeira, et al.
JAMA|June 10, 2004
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registryKim A Eagle, Michael J Lim, Omar H Dabbous, et al.
American Heart Journal|June 4, 2018
Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysisBenjamin M Scirica, Sameer Bansilal, Farideh Davoudi, et al.
Heart (British Cardiac Society)|March 12, 2008
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevationR D Lopes, K S Pieper, J R Horton, et al.
JAMA|November 17, 2014
Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarctionDuk-Woo Park, Robert M Clare, Phillip J Schulte, et al.
European Heart Journal Open|June 9, 2023
Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AFAlan John Camm, Jan Steffel, Saverio Virdone, et al.
American Heart Journal|March 21, 2016
Pooled analysis of adverse event collection from 4 acute coronary syndrome trialsAndré Zimerman, Renato D Lopes, Amanda L Stebbins, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 19, 2019
Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registryWerner Hacke, Jean-Pierre Bassand, Saverio Virdone, et al.
JAMA Cardiology|November 29, 2018
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation IIUtibe R Essien, DaJuanicia N Holmes, Larry R Jackson, et al.
Pageof 24